日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Sino Biopharm targets 30 innovative products by 2027

By Zhou Wenting in Shanghai | chinadaily.com.cn | Updated: 2025-03-21 14:23
Share
Share - WeChat

Sino Biopharmaceutical Limited, or Sino Biopharm, expects to have approximately five innovative products approved in China each year, bringing the total of its innovative products to at least 30 by 2027, the company announced at a conference on Thursday, where it released its 2024 annual results.

Such continuous innovation efforts demonstrate the company's commitment to meeting patients' clinical needs and contributing to the Healthy China initiative, said Theresa Tse, chairwoman of Sino Biopharm.

The report showed that the Hong Kong-listed company's dedication to innovation has paid off, with its 2024 operating revenue and net profit both achieving double-digit growth. The company reported a total revenue of 28.87 billion yuan ($3.98 billion), representing a 10.2 percent year-on-year increase, while adjusted net profit attributable to shareholders reached 3.46 billion yuan, a 33.5 percent surge.

For the first time, the company also achieved over 10-billion-yuan revenue from its innovative products last year, reaching 12.06 billion yuan, a 21.9 percent year-on-year growth, which accounts for 41.8 percent of the company's total revenue.

"Our relentless focus on innovation over the past decade has led to the establishment of innovative research and development platforms for dual antibodies and ADC (antibody-drug conjugate) drugs among others, resulting in a steady stream of innovative products," said Tse.

The number of innovative products by Sino Biopharm increased from three in 2018 to 17 by the end of 2024, according to the report. Last year alone, the company saw four first-class innovative medicines approved for market, making it the pharmaceutical enterprise with the largest number of such approvals in the year.

Looking ahead, Sino Biopharm anticipates the launch of several blockbuster products for treatment of lung cancer, chronic obstructive pulmonary disease, breast cancer, and others within the next three years.

The company also said that it has strategically positioned itself in the realm of artificial intelligence through collaborations, investments and localized applications. It plans to intensify its investments in AI, expanding its application across R&D, production, sales and functional management to propel corporate development and lead industry innovation upgrades.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 精品国产一区二区三区久久久久久 | 国产欧美在线视频 | 免费观看性欧美一级 | 四虎影院最新网址 | 日韩黄色视屏 | 污视频免费网站 | 毛片毛片毛片毛片毛片 | 欧美一级二级在线观看 | 男女黄 | 婷婷精品国产亚洲AV在线观看 | 秋霞av电影| 国产亚洲欧美一区二区 | xxx视频| 欧美高清成人 | 国产成人无码区免费内射一片色欲 | 性做久久久 | 欧美高清在线精品一区二区不卡 | 奇米影视在线 | 欧美精品一区二区在线观看 | 奇米影| 欧美日本国产 | 国产精品乱码一区二三区小蝌蚪 | 黄色一级毛片 | 日韩欧美亚洲一区 | 亚洲国产婷婷香蕉久久久久久99 | 在线观看视频色 | 正在播放国产精品 | 日本高清在线观看视频www | 国产成人高清 | 国产69精品久久久久99尤物 | 亚洲精品性视频 | 一级寡妇乱色毛片全18 | 成年免费大片黄在线观看岛国 | 国产欧美一区二区三区另类精品 | 人人九九精品 | 毛片在线视频观看 | 夜班护士与医生啪 | 久久1区| www.99色 | 岛国一区| 午夜视频免费国产在线 |